PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30061216-0	2018	Nelfinavir Induces Endoplasmic Reticulum Stress and Sensitizes Renal Cancer Cells to TRAIL.	Nelfinavir	0-10	TNF superfamily member 10	Homo sapiens	85-90	
30061216-3	2018	MATERIALS AND METHODS: Using renal cancer cells (769-P, 786-O, Caki-2), the ability of nelfinavir to induce ER stress and sensitize them to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) was tested.	Nelfinavir	87-97	TNF superfamily member 10	Homo sapiens	140-195	
30061216-3	2018	MATERIALS AND METHODS: Using renal cancer cells (769-P, 786-O, Caki-2), the ability of nelfinavir to induce ER stress and sensitize them to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) was tested.	Nelfinavir	87-97	TNF superfamily member 10	Homo sapiens	197-202	
30061216-6	2018	Nelfinavir induced ER stress and increased the expression of TRAIL death receptor (DR) 4 and DR5, sensitizing the cancer cells to TRAIL.	Nelfinavir	0-10	TNF superfamily member 10	Homo sapiens	61-66	
30061216-6	2018	Nelfinavir induced ER stress and increased the expression of TRAIL death receptor (DR) 4 and DR5, sensitizing the cancer cells to TRAIL.	Nelfinavir	0-10	TNF superfamily member 10	Homo sapiens	130-135	
30061216-8	2018	CONCLUSION: Nelfinavir induces ER stress in renal cancer cells and sensitizes them to TRAIL.	Nelfinavir	12-22	TNF superfamily member 10	Homo sapiens	86-91	
21697087-10	2011	We provide evidence that Nelfinavir-induced ER stress modulates DR5 expression in human glioblastoma multiforme cells and can enhance TRAIL efficacy.	Nelfinavir	25-35	TNF superfamily member 10	Homo sapiens	134-139	
19000651-0	2008	Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cells.	Nelfinavir	0-10	TNF superfamily member 10	Homo sapiens	19-24	
19000651-4	2008	Nelfinavir sensitized ovarian cancer cells to treatment with an apoptosis-inducing TRAIL receptor antibody due to upregulation of the TRAIL receptor DR5 as shown by RT-PCR and FACScan analysis.	Nelfinavir	0-10	TNF superfamily member 10	Homo sapiens	83-88	
19000651-4	2008	Nelfinavir sensitized ovarian cancer cells to treatment with an apoptosis-inducing TRAIL receptor antibody due to upregulation of the TRAIL receptor DR5 as shown by RT-PCR and FACScan analysis.	Nelfinavir	0-10	TNF superfamily member 10	Homo sapiens	134-139	
19000651-5	2008	We conclude that nelfinavir, an already approved drug, is a highly efficient agent against ovarian cancer cells and could sensitize ovarian cancer cells to TRAIL treatment, either therapeutically applied or endogenously produced by cells of the immune system.	Nelfinavir	17-27	TNF superfamily member 10	Homo sapiens	156-161	
21697087-0	2011	Modulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).	Nelfinavir	99-109	TNF superfamily member 10	Homo sapiens	154-209	
21697087-0	2011	Modulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).	Nelfinavir	99-109	TNF superfamily member 10	Homo sapiens	211-216